MEPAFAR study workgroup members are listed in the Appendix.
Agreement Between Community Pharmacy and Ambulatory and Home Blood Pressure Measurement Methods to Assess the Effectiveness of Antihypertensive Treatment: The MEPAFAR Study
Article first published online: 5 MAR 2012
© 2012 Wiley Periodicals, Inc.
The Journal of Clinical Hypertension
Volume 14, Issue 4, pages 236–244, April 2012
How to Cite
Sabater-Hernández, D., De La Sierra, A., Sánchez-Villegas, P., Santana-Pérez, F. M., Merino-Barber, L., Faus, M. J. and on behalf of the MEPAFAR Study Workgroup (2012), Agreement Between Community Pharmacy and Ambulatory and Home Blood Pressure Measurement Methods to Assess the Effectiveness of Antihypertensive Treatment: The MEPAFAR Study. The Journal of Clinical Hypertension, 14: 236–244. doi: 10.1111/j.1751-7176.2012.00598.x
- Issue published online: 28 MAR 2012
- Article first published online: 5 MAR 2012
- Manuscript received: December 6, 2011; Revised: December 27, 2011; Accepted: January 7, 2012
Table S1. Agreement between measurements methods using 135/85 mmHg cut-off points for the community pharmacy blood pressure measurement method. Sensitivity, specificity, positive and negative predictive values of community pharmacy blood pressure measurement method.
|JCH_598_sm_TableS1.doc||33K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.